2,4-diaminobutyric acid has been researched along with Benign Neoplasms, Brain in 2 studies
2,4-diaminobutyric acid: RN given refers to parent cpd without isomeric designation
2,4-diaminobutyric acid : A diamino acid that is butyric acid in which a hydrogen at position 2 and a hydrogen at position 4 are replaced by amino groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergenheim, AT | 1 |
Roslin, M | 1 |
Ungerstedt, U | 2 |
Waldenström, A | 1 |
Henriksson, R | 1 |
Ronquist, G | 2 |
Hugosson, R | 1 |
Sjölander, U | 1 |
1 trial available for 2,4-diaminobutyric acid and Benign Neoplasms, Brain
Article | Year |
---|---|
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB).
Topics: Aged; Aminobutyrates; Antimetabolites, Antineoplastic; Brain Neoplasms; Catheters, Indwelling; Dose- | 2006 |
1 other study available for 2,4-diaminobutyric acid and Benign Neoplasms, Brain
Article | Year |
---|---|
Treatment of malignant glioma by a new therapeutic principle.
Topics: Aminobutyrates; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Craniotomy; Dialy | 1992 |